Kenji Murata

Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy

Yuki Kagoya, Tingxi Guo, Brian Yeung et al. · Cancer Immunology Research · 2020 · 167 citations

High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma

Makoto Emori, Tomohide Tsukahara, Masaki Murase et al. · PLoS ONE · 2013 · 60 citations · Full text

Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells

Yuki Kagoya, Hiroshi Saijo, Yukiko Matsunaga et al. · Journal of Autoimmunity · 2018 · 44 citations

Suppressive Function, Epigenetic Change, T-regulatory Cell +11

Osteosarcoma‐initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B

Emi Mizushima, Tomohide Tsukahara, Makoto Emori et al. · Cancer Science · 2019 · 39 citations · Full text

Union rates and prognostic variables of osteoporotic vertebral fractures treated with a rigid external support

Kenji Murata, Goichi Watanabe, Satoshi Kawaguchi et al. · Journal of Neurosurgery Spine · 2012 · 37 citations